A physician-led explainer puts sexual symptoms, distress and context ahead of assumptions about age, with guidance on desire, discomfort and screening.
On October 25, 2026, Woman’s World published a physician-led explainer by Lisa Maxbauer about seven sexual-health misconceptions affecting women as they age. Its practical message shifts attention from a birthday on the calendar to the particular change someone wants to discuss.
The article addresses assumptions about desire and menopause-related discomfort alongside misunderstandings about sexually transmitted infections. The connecting point is straightforward: age alone should not replace a conversation about symptoms and their context. That does not mean every change is a disorder or requires treatment.
The Woman’s World article, available through Yahoo Health, organizes physician commentary around seven misconceptions. Steven Goldberg, MD, and Shernell Surratt-Gary, DO, discuss sexual difficulties and reasons to raise concerns in clinical care. The intended scope extends beyond menopause to include infection risk and screening.
This is not a study following a defined group of women. It reports no recruited sample, follow-up period or comparison between treatments. Its contribution is educational: it brings together clinical explanations that help readers distinguish different concerns rather than grouping them all under aging.
That distinction matters when reading its numerical estimates and treatment examples. The article offers a framework for discussion rather than a new measurement of how sexual function changes over time. Its central question is whether a specific concern is being overlooked because of an assumption about age or sexuality.
Surratt-Gary distinguishes spontaneous desire from responsive desire. In the article, she explains that desire may develop after affection, stimulation or connection begins. The absence of an immediate feeling of desire is therefore not automatically evidence that something is wrong.
The important clinical distinction is whether low desire causes distress. Surratt-Gary says assessment may consider medications and mood alongside sleep and pain. Hormones and other medical conditions also belong in that assessment rather than serving as the presumed explanation from the outset.
This shifts the question from whether desire matches a familiar expectation to whether its current pattern is troubling. It also makes room for a more specific description than simply saying that libido has changed. The article treats the experience and its impact as relevant information.
The explainer challenges the idea that vaginal dryness or painful sex after menopause must simply be endured. It identifies genitourinary syndrome of menopause, often shortened to GSM, as a possible explanation for these symptoms.
The article names vaginal moisturizers and lubricants among the options discussed for GSM. It also mentions low-dose vaginal estrogen. These examples support its broader point that menopause-related discomfort is a legitimate topic for clinical care rather than something that must remain unspoken.
Pain and reduced desire are different descriptions of an experience. Keeping them distinct makes the conversation more precise. Sexential’s coverage of menopause-related comfort and changing desire provides related context without treating those concerns as interchangeable.
Goldberg estimates in the article that sexual difficulties affect 40 to 50 percent of women. His examples include low desire and arousal difficulty as well as orgasm problems and pain. He presents these concerns as medical matters rather than evidence of personal failure.
Another misconception addressed by the article is that raising sexual health with a doctor is embarrassing. Its experts encourage patients to bring concerns into clinical discussion. The useful message is not that someone must describe every aspect of their sexual life, but that a symptom affecting wellbeing belongs in the conversation.
The article also challenges the assumption that an absence of symptoms rules out a sexually transmitted infection. It rejects the idea that these infections concern only young or single people. Its guidance places exposure and risk ahead of age or relationship status when discussing testing.
A related distinction concerns Pap tests. The physicians caution that a Pap test should not be assumed to provide STI screening. They encourage patients to ask which tests are appropriate and what testing actually includes.
These points broaden the explainer beyond hormonal change. A question about dryness is not the same as a question about infection exposure. Both deserve clear language rather than reassurance based only on someone’s age.
The prevalence estimate comes from an interviewed physician rather than a newly reported population study. How sexual dysfunction is defined and measured also affects prevalence. It should not be read as a precise estimate of how many women of a particular age need clinical treatment.
The article does not establish what caused an individual woman’s symptoms. It also does not compare the effectiveness or suitability of the treatment options it mentions. Naming an option is different from showing that it is appropriate for every person with a similar complaint.
Its menopause discussion should not be read as evidence that aging has no influence on sexual function. The narrower point is that experiences vary and age alone is an incomplete explanation. The practical value lies in identifying the concern accurately enough for an individualized assessment.
The explainer’s emphasis on context fits the Merck Manuals guidance on sexual interest and arousal issues. That guidance describes duration and significant distress as parts of diagnostic assessment. It also considers whether another mental-health or general medical condition better explains the symptoms.
For sexual interest/arousal disorder, Merck describes symptoms lasting at least six months among the diagnostic criteria. That duration is part of a clinical definition. It is not an instruction to wait before discussing a concern or proof that any reduction in interest lasting that long is a disorder.
Merck also says a pelvic examination is performed when pain or other physical symptoms are present. This reinforces the value of distinguishing a change in interest from a concern involving physical discomfort. Different descriptions can lead to different assessment questions.
Together, these sources put the Woman’s World advice in perspective. The update does not replace established clinical reasoning with a new theory about aging. It makes that reasoning more accessible by showing why the symptom and its impact matter more than a broad label.
For readers whose main concern is desire, Sexential’s discussion of influences beyond hormones offers a related educational perspective. The aim is to keep several possible contributors in view without assuming that all are relevant to every person.
The most practical takeaway is a way to organize information for a qualified clinician. The article supports describing what has changed and when it began. It also supports explaining whether the change causes distress or affects wellbeing or a relationship.
A useful summary can keep three elements separate:
This is a conversation aid rather than a self-diagnostic checklist. Someone describing pain is giving different information from someone describing desire that now develops more gradually. Keeping those details separate helps preserve the distinction the physicians are making.
The same approach applies to questions about possible contributors. A clinician may consider medication effects and mood alongside sleep and pain. Hormonal or other medical factors can then be discussed within that wider picture instead of becoming the automatic answer.
For infection concerns, the practical question is more direct: which tests are appropriate for the exposure being discussed? Asking what a proposed panel includes follows the article’s advice. It avoids assuming that a Pap test or a broadly described screening panel answers every STI question.
Persistent or distressing symptoms deserve discussion with a clinician. A change that does not cause distress need not be treated as a disorder simply because it differs from an earlier stage of life. The sources support individualized assessment rather than a requirement to restore a particular pattern of sexual response.
The calendar still has a place in the conversation because life stage provides context. But a birthday is not the whole explanation. The more useful starting point is the experience itself: what changed and what it means to the person living with it.
Describing a sexual change is the reader’s part of a clinical conversation; Sexential adds clear educational context about sexual wellbeing. For adults aged 35 to 65, its coverage connects biology with confidence and relationships to address uncertainty about influences on sexual function without offering personalised medical advice.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
A practical guide to sustainable movement, sexual confidence and the evidence on erectile function, without making exercise a test of sexual performance.
A grounded guide for men and couples to understand libido changes through health, stress, medicines and relationship context, without assuming one cause.
A survey of 660 Hone Health members highlights perimenopause uncertainty. Read the findings, limits and separate context for sexual wellbeing.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
